药物发现
药物开发
生物
计算生物学
鉴定(生物学)
药品
铅(地质)
过程(计算)
候选药物
药理学
生化工程
风险分析(工程)
生物信息学
计算机科学
业务
工程类
操作系统
古生物学
植物
作者
Vesna Eraković Haber,Radan Spaventi
出处
期刊:Progress in molecular and subcellular biology
日期:2017-01-01
卷期号:: 91-104
被引量:8
标识
DOI:10.1007/978-3-319-51284-6_3
摘要
Drug discovery and development process is nowadays conducted in relatively standardised sequence of phases, starting with Discovery and being followed by Preclinical, Clinical and Non-Clinical Development. Discovery phase is divided in Hit Finding, Lead generation, Lead Optimisation and Candidate Identification Phase. Main drivers of the whole process are regulatory requirements and the aim to eliminate the unnecessary spending by early elimination of unlikely drug candidates. Marine products, once purified, isolated and produced in required quantities, follow the same route as any other synthetic drug.
科研通智能强力驱动
Strongly Powered by AbleSci AI